Perigon Wealth Management »

Diamedica Therapeutics shares owned by Perigon Wealth Management

Quarter-by-quarter ownership of Diamedica Therapeutics (DMAC) shares owned by Perigon Wealth Management from 13F filings

Historical chart of Perigon Wealth Management investment in Diamedica Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Diamedica Therapeutics held by Perigon Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Diamedica Therapeutics by Perigon Wealth Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $95k 14k 6.77
2025-06-30 $207k 53k 3.90

More positions owned by Perigon Wealth Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Microsoft Corporation (MSFT)
Spdr Series Trust State Street Spd (BIL)
Alphabet Cap Stk Cl A (GOOGL)
Gmo Etf Trust Gmo Us Quality E (QLTY)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
J P Morgan Exchange Traded F Betabuildrs Us (BBUS)

View all positions for Perigon Wealth Management

Top funds holding Diamedica Therapeutics

Omega Advisors
BlackRock
Paragon Associates & Paragon Associates Ii Joint Venture
Millennium Management
Geode Capital Management
Vanguard Group
State Street Corporation
First Manhattan
Bleichroeder
Northern Trust
Advisor Group Holdings
LPL Financial
Citadel Advisors
Goldman Sachs Group
Bank of New York Mellon

View all funds holding Diamedica Therapeutics